217 related articles for article (PubMed ID: 25108533)
1. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
Unemo M; Golparian D; Hestner A
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
[TBL] [Abstract][Full Text] [Related]
3. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
4. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
5. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442
[TBL] [Abstract][Full Text] [Related]
6. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
7. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods.
Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D
J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant
Poncin T; Fouere S; Braille A; Camelena F; Agsous M; Bebear C; Kumanski S; Lot F; Mercier-Delarue S; Ngangro NN; Salmona M; Schnepf N; Timsit J; Unemo M; Bercot B
Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845928
[TBL] [Abstract][Full Text] [Related]
9. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
10. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
[TBL] [Abstract][Full Text] [Related]
12. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
Unemo M
BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant
Golparian D; Rose L; Lynam A; Mohamed A; Bercot B; Ohnishi M; Crowley B; Unemo M
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482267
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
Unemo M; Golparian D; Eyre DW
Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
18. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S
J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347
[TBL] [Abstract][Full Text] [Related]
19. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
20. Background review for the '2020 European guideline for the diagnosis and treatment of gonorrhoea in adults'.
Unemo M; Ross J; Serwin AB; Gomberg M; Cusini M; Jensen JS
Int J STD AIDS; 2021 Feb; 32(2):108-126. PubMed ID: 33323071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
